A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema

These results demonstrate that intravitreal bevacizumab can reduce DME in some eyes, but the study was not designed to determine whether treatment is beneficial. A phase III trial would be needed for that purpose.